Table 1.

Baseline characteristics of JOS-C study participants at the time of JOS study exit (age 6 y)

Baseline characteristics at age 6 yEarly prophylaxisDelayed prophylaxisP
Participants in analysis, n 15 18  
Age of prophylaxis initiation, mean (SD), y 1.3 (0.4) 7.6 (3.5) <.0001 
MRI OC damage, n/N (%)    
 Boys with OC damage 1/15 (6.7) 9/18 (50) .020 
 Joints with OC damage 1/89 (1) 9/102 (9) .021 
No MRI damage, eMRI score < 1, n/N (%)    
 Boys with no damage 11/15 (73) 6/18 (33) .022 
 Joints with no damage 85/89 (96) 81/102 (79) .001 
eMRI, median (IQR) of participant joint averages    
 MRI score 0.08 (0-0.3) 0.6 (0.02-1.7) .07 
 OC MRI score 0 (0-0) 1.2 (0.3-3.1) .05 
ABR prior to age 6 y, mean (SD)    
 Joint ABR 0.7 (0.8) 3.8 (2.8) .0002 
 ABR 3.2 (3.1) 14.4 (6.6) .0072 
CPJAS, average per joint, mean (SD)    
 Physical examination score 1.0 (0.9) 1.7 (1.4) .094 
Baseline characteristics at age 6 yEarly prophylaxisDelayed prophylaxisP
Participants in analysis, n 15 18  
Age of prophylaxis initiation, mean (SD), y 1.3 (0.4) 7.6 (3.5) <.0001 
MRI OC damage, n/N (%)    
 Boys with OC damage 1/15 (6.7) 9/18 (50) .020 
 Joints with OC damage 1/89 (1) 9/102 (9) .021 
No MRI damage, eMRI score < 1, n/N (%)    
 Boys with no damage 11/15 (73) 6/18 (33) .022 
 Joints with no damage 85/89 (96) 81/102 (79) .001 
eMRI, median (IQR) of participant joint averages    
 MRI score 0.08 (0-0.3) 0.6 (0.02-1.7) .07 
 OC MRI score 0 (0-0) 1.2 (0.3-3.1) .05 
ABR prior to age 6 y, mean (SD)    
 Joint ABR 0.7 (0.8) 3.8 (2.8) .0002 
 ABR 3.2 (3.1) 14.4 (6.6) .0072 
CPJAS, average per joint, mean (SD)    
 Physical examination score 1.0 (0.9) 1.7 (1.4) .094 

Numbers expressed as mean (SD) or median (IQR) for continuous variables depending on normal or skewed distribution, and number (percentage) for count variables. Maximum CPJAS score, 31 points per joint; maximum MRI score, 45 per joint; maximum OC score, 36 per joint.

OC, osteochondral.

Close Modal

or Create an Account

Close Modal
Close Modal